A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Wendler, Jason P ^a,d,e   Okombo, John ^b   Amato, Roberto ^a,d,e   Miotto, Olivo ^a,c,d,e   Kiara, Steven M ^b   Mwai, Leah ^b   Pole, Lewa ^b   O'Brien, John ^a,d,e   Manske, Magnus ^d   Alcock, Dan ^d   Drury, Eleanor ^d   Sanders, Mandy ^d   Oyola, Samuel O ^d   Malangone, Cinzia ^d   Jyothi, Dushyanth ^d   Miles, Alistair ^a,d,e   Rockett, Kirk A ^a,d,e   MacInnis, Bronwyn L ^a,d   Marsh, Kevin ^b   Bejon, Philip ^a,b,e   Nzila, Alexis ^f   Kwiatkowski, Dominic P ^a,d,e   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c MAHIDOL UNIVERSITY   (Thailand)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINOLINE DERIVATIVE; AMODIAQUINE; ANTIMALARIAL AGENT; BISQUINOLINE DERIVATIVE; CHLOROQUINE; DEETHYLAMODIAQUINE; PIPERAQUINE; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; PYRONARIDINE; QUINAZOLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; PROTOZOAL DNA;

ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CHILD; CONTROLLED STUDY; CRT GENE; DHFR GENE; DHPS GENE; GENE; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; KENYA; MALARIA; MDR1 GENE; MICROBIAL GROWTH; NHE GENE; NONHUMAN; PARASITE ISOLATION; PFCRT GENE; PLASMODIUM FALCIPARUM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MALARIA FALCIPARUM; PARASITOLOGY;

ANTIMALARIALS; CHILD; DNA, PROTOZOAN; DRUG RESISTANCE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KENYA; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84901490769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096486     Document Type: Article

References (50)

1. DOMC (2009) National Malaria Strategy 2009-2017. Kenya Division of Malaria Control Ministry of Public Health and Sanitation.
2. WHO (2011) World Malaria Report 2011. World Health Organization.
3. Sibley CH, Guerin PJ, Ringwald P (2010) Monitoring antimalarial resistance: launching a cooperative effort. Trends in parasitology 26: 221-224.
4. Ecker A, Lehane AM, Clain J, Fidock DA (2012) PfCRT and its role in antimalarial drug resistance. Trends in parasitology 28: 504-514.
5. Wellems TE, Walker-Jonah A, Panton LJ (1991) Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proceedings of the National Academy of Sciences of the United States of America 88: 3382-3386. (Pubitemid 21916625)
6. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, et al. (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular cell 6: 861-871.
7. Kiara SM, Okombo J, Masseno V, Mwai L, Ochola I, et al. (2009) In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation. Antimicrobial agents and chemotherapy 53: 3793-3798.
8. Mwai L, Kiara SM, Abdirahman A, Pole L, Rippert A, et al. (2009) In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrobial agents and chemotherapy 53: 5069-5073.
9. Okombo J, Kiara SM, Rono J, Mwai L, Pole L, et al. (2010) In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya. Antimicrobial agents and chemotherapy 54: 3302-3307.
10. Van Tyne D, Park DJ, Schaffner SF, Neafsey DE, Angelino E, et al. (2011) Identification and functional validation of the novel antimalarial resistance locus PF10-0355 in Plasmodium falciparum. PLoS genetics 7: e1001383.
11. Malaria Genomic Epidemiology Network (2008) A global network for investigating the genomic epidemiology of malaria. Nature 456: 732-737.
12. Sasi P, Abdulrahaman A, Mwai L, Muriithi S, Straimer J, et al. (2009) In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East Africa. The Journal of infectious diseases 199: 1575-1582.
13. Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, et al. (2011) Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PloS one 6: e26005.
14. Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, et al. (2012) Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature 487: 375-379.
15. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 100: 9440-9445. (Pubitemid 37033947)
16. Su X, Kirkman LA, Fujioka H, Wellems TE (1997) Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91: 593-603. (Pubitemid 27513651)
17. Fidock DA, Nomura T, Cooper RA, Su X, Talley AK, et al. (2000) Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum. Molecular and biochemical parasitology 110: 1-10.
18. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, et al. (2002) Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418: 320-323. (Pubitemid 34790681)
19. Zheng G, Freidlin B, Gastwirth JL (2006) Robust genomic control for association studies. American journal of human genetics 78: 350-356. (Pubitemid 43157574)
20. Duah NO, Quashie NB, Abuaku BK, Sebeny PJ, Kronmann KC, et al. (2012) Surveillance of Molecular Markers of Plasmodium falciparum Resistance to Sulphadoxine-Pyrimethamine 5 Years after the Change of Malaria Treatment Policy in Ghana. The American journal of tropical medicine and hygiene.
21. Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Jahevitra M, Rabearimanana S, et al. (2009) Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrobial agents and chemotherapy 53: 4588-4597.
22. Ferdig MT, Cooper RA, Mu J, Deng B, Joy DA, et al. (2004) Dissecting the loci of low-level quinine resistance in malaria parasites. Molecular microbiology 52: 985-997. (Pubitemid 38916169)
23. Henry M, Briolant S, Zettor A, Pelleau S, Baragatti M, et al. (2009) Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine. Antimicrobial agents and chemotherapy 53: 1926-1930.
24. Yuan J, Cheng KC, Johnson RL, Huang R, Pattaradilokrat S, et al. (2011) Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science 333: 724-729.
25. Sisowath C, Petersen I, Veiga MI, Martensson A, Premji Z, et al. (2009) In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. The Journal of infectious diseases 199: 750-757.
26. Basco LK, Ringwald P (2003) In vitro activities of piperaquine and other 4- aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon. Antimicrobial agents and chemotherapy 47: 1391-1394. (Pubitemid 36368602)
27. Watkins WM, Sixsmith DG, Spencer HC, Boriga DA, Kariuki DM, et al. (1984) Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet 1: 357-359. (Pubitemid 14183278)
28. Shretta R, Omumbo J, Rapuoda B, Snow RW (2000) Using evidence to change antimalarial drug policy in Kenya. Tropical medicine & international health: TM & IH 5: 755-764. (Pubitemid 32001034)
29. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, et al. (2009) Chloroquine resistance before and after its withdrawal in Kenya. Malaria journal 8: 106.
30. WHO (2007) Antimalarial Medicines in Kenya. A baseline study undertaken prior to nationwide distribution of artmether-lumefantrine (AL) in Kenya. World Health Organization.
31. Daily JP, Roberts C, Thomas SM, Ndir O, Dieng T, et al. (2003) Prevalence of Plasmodium falciparum pfcrt polymorphisms and in vitro chloroquine sensitivity in Senegal. Parasitology 126: 401-405. (Pubitemid 36649294)
32. Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, et al. (2006) Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 6: 309-314.
33. Ochong EO, van den Broek IV, Keus K, Nzila A (2003) Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. The American journal of tropical medicine and hygiene 69: 184-187.
34. Beshir K, Sutherland CJ, Merinopoulos I, Durrani N, Leslie T, et al. (2010) Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76. Antimicrobial agents and chemotherapy 54: 3714-3716.
35. Nsobya SL, Dokomajilar C, Joloba M, Dorsey G, Rosenthal PJ (2007) Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda. Antimicrobial agents and chemotherapy 51: 3023-3025. (Pubitemid 47206253)
36. Sa JM, Twu O, Hayton K, Reyes S, Fay MP, et al. (2009) Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proceedings of the National Academy of Sciences of the United States of America 106: 18883-18889.
37. Combrinck JM, Mabotha TE, Ncokazi KK, Ambele MA, Taylor D, et al. (2013) Insights into the role of heme in the mechanism of action of antimalarials. ACS chemical biology 8: 133-137.
38. Ginsburg H, Famin O, Zhang J, Krugliak M (1998) Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochemical pharmacology 56: 1305-1313. (Pubitemid 28511267)
39. Heis MD, Ditmer EM, de Oliveira LA, Frazzon AP, Margis R, et al. (2011) Differential expression of cysteine desulfurases in soybean. BMC plant biology 11: 166.
40. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, et al. (2003) Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. The Journal of infectious diseases 187: 1870-1875. (Pubitemid 36724485)
41. Mita T, Kaneko A, Lum JK, Zungu IL, Tsukahara T, et al. (2004) Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Molecular and biochemical parasitology 135: 159-163. (Pubitemid 38470086)
42. Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, et al. (2010) Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. The Journal of infectious diseases 202: 801-808.
43. Bray PG, Deed S, Fox E, Kalkanidis M, Mungthin M, et al. (2005) Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum. Biochemical pharmacology 70: 1158-1166. (Pubitemid 41317510)
44. Martin SK, Oduola AM, Milhous WK (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235: 899-901. (Pubitemid 17019130)
45. Patel JJ, Thacker D, Tan JC, Pleeter P, Checkley L, et al. (2010) Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross. Molecular microbiology 78: 770-787.
46. Vale N, Moreira R, Gomes P (2009) Primaquine revisited six decades after its discovery. European journal of medicinal chemistry 44: 937-953.
47. Baird JK, Surjadjaja C (2011) Consideration of ethics in primaquine therapy against malaria transmission. Trends in parasitology 27: 11-16.
48. Park DJ, Lukens AK, Neafsey DE, Schaffner SF, Chang HH, et al. (2012) Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite. Proceedings of the National Academy of Sciences of the United States of America 109: 13052-13057.
49. Okombo J, Kiara SM, Mwai L, Pole L, Ohuma E, et al. (2012) Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya. Antimicrobial agents and chemotherapy 56: 1105-1107.
50. O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, et al. (2008) Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 372: 1555-1562.